UAB 1017/TBCRC 008: A Multi-Institutional Double-Blind Phase II Study Evaluating Response and Surrogate Biomarkers to Carboplatin and nab-Paclitaxel (CP)With or Without Vorinostat as Preoperative Chemotherapy in HER-2 Negative Primary Operable Breast Cancer

Grant

Total Award Amount

  • 10360.00
  • Direct Costs

  • 8222.00
  • Sponsor Award Id

  • SKCCCJ0785
  • Contributor

  • John Carpenter   Principal Investigator